COVID-19 Report #1: Rubicon Strategy
The lobbying firm helping Big Pharma influence Doug Ford's Ontario government
COVID-19 Report #1: Rubicon Strategy
Welcome to the first report in this new series. This focuses on Rubicon Strategy, a lobbying firm operating in Ottawa and Toronto that has tremendous conflicts of interest in the COVID-19 policymaking process.
The full report is included here, and I encourage you to download a copy for yourself to print and distribute, or simply for archival purposes. No need to credit me as the information itself is what’s important.
I’ll provide the executive summary in this message, after which you’ll see the button to read the PDF report.
An important note: everything I write about is fully sourced, referenced and cited. I’m not making anything up. I am not unbiased, but I am deeply committed to evidence-based science and reporting, and will do nothing less than that here. Most importantly, all my resources are included for you to “fact-check” for yourself and evaluate their reliability and verifiability.
Executive Summary:
Rubicon Strategy is a lobbying firm being used to “launder” influence from major stakeholders in the COVID-19 crisis, including all of the major pharmaceutical companies. The result is highly biased, aggressively pro-vaccination policy stemming from the Ontario Provincial Government, falling in lockstep with jurisdictions across Canada and around the world. The COVID-19 response has been based not on science or the well-being of Ontarians, but instead the financial and ideological interests of multinational corporations and supranational non-governmental organizations (NGOs).
The team at Rubicon is made up almost entirely of high-level campaign officials from Doug Ford’s successful 2018 election for Premier of Ontario, and others who have held senior positions in Ford’s government (and in some cases, former Prime Minister Stephen Harper’s federal government) before joining Rubicon;
CEO Kory Teneycke is currently campaign manager for the Progressive Conservative Party in the 2022 election, while his company is actively lobbying Ford and the party for their own interests;
The following companies, directly or through related organizations, are actively influencing Ontario’s policies around COVID-19 and broader pharmaceutical regulations: Providence Therapeutics, Medical Pharmacies Group Ltd, AstraZeneca, Amgen, Bayer, GlaxoSmithKline, Merck, Pfizer, Amazon, Janssen, Johnson & Johnson, AbbVie, Bristol-Myers Squibb, Eli Lilly, Emergent Biosolutions, Gilead, Roche, Medicago, Novartis, Sanofi, and Arbor Memorial Inc;1
The following healthcare, academic and hospitality organizations are doing the same: the Ontario Medical Association, Ontario Hospital Association, Sienna Senior Living, Ontario Association of Radiologists, Canadian Niagara Hotels Inc, CareRx, and the Council of Ontario Universities;
The companies who currently or previously engage government through Rubicon Strategy are deeply troubling as their stated values, goals and associations do not necessarily align with those of the voting Canadian population. AstraZeneca, Bayer, Merck, Pfizer, Amazon, Johnson & Johnson, Abbott (associated with AbbVie), Roche, Novartis, Sanofi, Manulife, Mott MacDonald and IBM are all Member Organizations of the World Economic Forum, lead by Klaus Schwab (author of “The Great Reset”).2
Rubicon Strategy must immediately stop its lobbying activities due to sufficient evidence of Conflict of Interest, and its employees investigated to ensure there is no undue influence that may violate Canadian law and threaten the safety and well-being of Canadians.
See Appendix A for background information surrounding these companies and COVID-19
See Appendix B for citations regarding membership with the World Economic Forum
Thank you, this is very interesting!